Recurrent cholangiocarcinoma with long-term survival by multimodal treatment: A case report

Mostrar otras versiones (1)

Long-term outcomes after surgical resection of bile duct cancer remain unsatisfactory, and survival, particularly after tumor recurrence, is poor. Gemcitabine and cisplatin combination (GC) therapy is the standard first-line treatment; however, second-line approaches are yet to be established. Radio...

Descripción completa

Detalles Bibliográficos
Autores principales: Sota, Yuki, Einama, Takahiro, Kobayashi, Kazuki, Fujinuma, Ibuki, Tsunenari, Takazumi, Takihata, Yasuhiro, Iwasaki, Toshimitsu, Miyata, Yoichi, Okamoto, Koichi, Kajiwara, Yoshiki, Shinto, Eiji, Tsujimoto, Hironori, Yasuda, Shigeo, Isozaki, Yuka, Yamada, Shigeru, Yamamoto, Junji, Ueno, Hideki, Kishi, Yoji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907798/
https://www.ncbi.nlm.nih.gov/pubmed/33732458
http://dx.doi.org/10.3892/mco.2021.2234

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907798/
https://www.ncbi.nlm.nih.gov/pubmed/33732458
http://dx.doi.org/10.3892/mco.2021.2234

Ejemplares similares